Cord Blood Banking Market (By Type of Bank: Public, Private; By Services: Processing, Storage, Others; By Application: Cancer, Blood Disorders, Bone Marrow Failure Syndrome, Immuno-deficiency Disorders, Metabolic Disorders; By End Use: Hospital, Research Institutes, Specialty Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cord Blood Banking Market 

5.1. COVID-19 Landscape: Cord Blood Banking Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cord Blood Banking Market, By Type of Bank

8.1. Cord Blood Banking Market, by Type of Bank, 2024-2033

8.1.1. Public

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Private

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Cord Blood Banking Market, By Services

9.1. Cord Blood Banking Market, by Services, 2024-2033

9.1.1. Processing

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Storage

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Cord Blood Banking Market, By Application 

10.1. Cord Blood Banking Market, by Application, 2024-2033

10.1.1. Cancer

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Blood Disorders

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Bone Marrow Failure Syndrome

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Immuno-deficiency Disorders

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Metabolic Disorders

10.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Cord Blood Banking Market, By End Use 

11.1. Cord Blood Banking Market, by End Use, 2024-2033

11.1.1. Hospital

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Research Institutes

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Specialty Clinics

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Cord Blood Banking Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.1.2. Market Revenue and Forecast, by Services (2021-2033)

12.1.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.4. Market Revenue and Forecast, by End Use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Services (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End Use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Services (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End Use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.2.2. Market Revenue and Forecast, by Services (2021-2033)

12.2.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.4. Market Revenue and Forecast, by End Use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Services (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End Use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Services (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End Use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Services (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End Use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Services (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End Use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.3.2. Market Revenue and Forecast, by Services (2021-2033)

12.3.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.4. Market Revenue and Forecast, by End Use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Services (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End Use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Services (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End Use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Services (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End Use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Services (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End Use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.4.2. Market Revenue and Forecast, by Services (2021-2033)

12.4.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.4. Market Revenue and Forecast, by End Use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Services (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End Use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Services (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End Use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Services (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End Use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Services (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End Use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.5.2. Market Revenue and Forecast, by Services (2021-2033)

12.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.4. Market Revenue and Forecast, by End Use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Services (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End Use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type of Bank (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Services (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End Use (2021-2033)

Chapter 13. Company Profiles

13.1. Thermo Fisher Scientific (US)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Merck KGaA (Germany)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Lonza Group (Switzerland)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. STEMCELL Technologies (Canada)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Takara Bio (Japan)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. FUJIFILM Cellular Dynamics (US)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Sartorius AG (Germany)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. GE Healthcare (UK)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Charles River Laboratories International (US)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Cynata Therapeutics (Australia)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample